Integra Lifesciences Holdings IART
NASDAQ IART
$16.59 -0.65 (-3.77%)
As of: Aug 20, 2026 · 3:59 PM EDT

Integra Lifesciences Holdings (IART) Receivables - Net (2009 - 2026)

Integra Lifesciences Holdings (IART) posted Receivables - Net of $267.2 million for Q2 2026, up 1.05% sequentially from $264.4 million in Q1 2026, and down 6.09% YoY from $284.5 million in Q2 2025.

Integra Lifesciences Holdings (IART) Receivables - Net (2009 - 2026) Analysis & Trends

Integra Lifesciences Holdings has reported Receivables - Net for 18 years, with the latest figure at $267.2 million in Q2 2026.

  • Quarterly Receivables - Net fell 6.09% year-over-year to $267.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $267.2 million (down 6.09% YoY) and the FY2025 annual result came in at $278.8 million, up 2.38% from the prior year.
  • Receivables - Net improved to $267.2 million in Q2 2026 per IART's latest filing, from $264.4 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $284.5 million in Q2 2025 and troughed at $234.0 million in Q1 2022.
  • A 5-year average of $258.5 million and a median of $259.0 million in 2023 frame the typical range for Receivables - Net.
  • The sharpest annual moves came in 2022 and 2026: Receivables - Net grew 13.65% in 2022, then fell 6.09% in 2026.
  • Over 5 years, Receivables - Net stood at $263.5 million in 2022, then slipped by 1.57% to $259.3 million in 2023, then rose by 5.03% to $272.4 million in 2024, then grew by 2.38% to $278.8 million in 2025, then declined by 4.18% to $267.2 million in 2026.
  • According to Business Quant data, Receivables - Net over the past three periods registered $267.2 million, $264.4 million, and $278.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Integra Lifesciences Holdings 1.28 Bn 1.01 Bn 219.74 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 267.19 Mn
Jun 30, 2026 267.19 Mn
Mar 31, 2026 264.41 Mn
Mar 31, 2026 264.41 Mn
Dec 31, 2025 278.85 Mn
Dec 31, 2025 278.85 Mn
Sep 30, 2025 262.16 Mn
Sep 30, 2025 262.16 Mn
Jun 30, 2025 284.51 Mn
Jun 30, 2025 284.51 Mn
Mar 31, 2025 252.45 Mn
Mar 31, 2025 252.45 Mn
Dec 31, 2024 272.37 Mn
Dec 31, 2024 272.37 Mn
Sep 30, 2024 248.30 Mn
Sep 30, 2024 248.30 Mn
Jun 30, 2024 271.16 Mn
Jun 30, 2024 271.16 Mn
Mar 31, 2024 241.09 Mn
Mar 31, 2024 241.09 Mn